Mereo BioPharma Group (STU:MAH0) 3-Year Book Growth Rate : -27.20% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Mereo BioPharma Group 3-Year Book Growth Rate?

Mereo BioPharma Group's Book Value per Share for the quarter that ended in Dec. 2024 was €0.38.

During the past 12 months, Mereo BioPharma Group's average Book Value per Share Growth Rate was 8.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was -27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Mereo BioPharma Group was -27.20% per year. The lowest was -46.50% per year. And the median was -33.45% per year.

Competitive Comparison of Mereo BioPharma Group's 3-Year Book Growth Rate

For the Biotechnology subindustry, Mereo BioPharma Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Mereo BioPharma Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Mereo BioPharma Group (STU:MAH0) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Mereo BioPharma Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (STU:MAH0) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

MREO:USA 0A9G:UK

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines